ECONSAP
Research Group on Health Economics in Primary Care
Multidisciplinary group composed of 21 researchers, six general practitioners (3 of them are also doctors in medicine), a peditrian, two practitioner, nurses, five doctors in psychology, four doctors in pharmacy, two pharmacy graduates and a doctor in psychiatry. The group originated in 1999 under the name GRAPISAM Group (Research Group in Primary Care and Mental Health) with the development of the DAPGA study that was carried out in the Mental Health Center of Gavà and the ABS Bartolomé Fabrés Anglada of Gavà. As a result of that first collaboration, others emerged, such as the ETAPS, FIBROQOL and PRODEFAR studies, which focused mainly on the evaluation of interventions aimed at the management of mental illnesses in primary care, always with a focus on health economics. In recent years, the group has grown, becoming more multidisciplinary, expanding the focus of research and increasingly specializing in the economic evaluation of health in primary care, including the evaluation of the economic impact of diseases (eg COSTDEP), the cost-effectiveness of preventive interventions (eg PREDICTD-CCRT), the cost-effectiveness of pharmacological treatments (eg INFAP) and non-pharmacological treatments (eg EUDAIMON), the cost of non-adherence and the impact of the introduction of health policies (eg NO-Iniciadores), etc. In addition, although the study of mental illnesses is still one of the main focuses of the group, the research has been extended to other pathologies, such as the management of chronic pain and fibromyalgia (eg Fibromyalgia subtypes and EUDAIMON) or multi-risk prevention (eg Econ-EIRA3). The group complements the use of clinical trials and economic evaluations with other study designs that allow it to better understand the difficulties of managing pathologies in primary care and the efficiency of treatments, such as psychometric analysis (WHODAS 2.0, CERQ, FFMQ, MISCI, etc.), qualitative research (eg, PREDICT-EVAL), systematic reviews (eg EIRA2), and epidemiological studies based on the secondary exploitation of large databases, such as SIDIAP, all within the framework of research in the field of primary care. This evolution has given way to the Research Group on Health Economics in Primary Care (ECONSAP). The group's core objectives involve improving the quality and efficiency of care for mental pathologies and chronic physical diseases in primary care, including prevention and both pharmacological and non-pharmacological treatments. They aim to evaluate the cost of diseases and patient behavior, developing innovative and multidisciplinary interventions from a holistic standpoint within the primary care domain.
Group projects
|
PI: Rubio Valera, Maria. Avaluació de l'efectivitat i cost-efectivitat de la intervenció d'Adherència Inicial a la Medicació (IMA): Assaig controlat aleatoritzat per conglomerats i model econòmic (IMA-cRCT). Funding: Fundació per a la recerca i la docència Sant Joan de Déu (FSJD). Duration: 2021 - 2023 |
|
PI: Luciano Devis, Juan Vicente. Coste-utilidad y efectos fisiológicos de la Terapia de Aceptación y Compromiso y la Activación Conductual en pacientes con dolor crónico y depresión mayor comórbida (Proyecto IMPACT). Funding: Instituto de Salud Carlos III. Duration: 2020 - 2022 |
|
PI: Vicens Pons, Enric. Cohorte DESVELA. Análisis del papel de las aptitudes personales como DEterminantes de la incidencia de morbilidad, eStilos de vida, calidad de Vida, uso de sErvicios y mortaLidAd.. Funding: Instituto de Salud Carlos III. Duration: 2020 - 2022 |
|
PI: Rubio Valera, Maria. Pilot d'una intervenció complexa per millorar la iniciació al tractament farmacològic. Funding: Fundació per a la recerca i la docència Sant Joan de Déu (FSJD). Duration: 2020 - 2022 |
|
PI: Mendive Arbeloa, Juan Manuel. Developing, implementing and evaluating a clinical care pathway for NASH primary care patients: a multi-centre study. Funding: Gilead Sciences, S.L.U. Duration: 2020 - 2022 |
|
PI: Rubio Valera, Maria. El problema de la no iniciación pedíatrica: Evaluación con métodos mixtos. Funding: Instituto de Salud Carlos III. Duration: 2020 - 2022 |
|
PI: Mendive Arbeloa, Juan Manuel. Prevención de la depresión a través de una intervención personalizada basada en TICs, algoritmos predictivos de riesgo, y DSS para pacientes y médicos de familia: El estudio e-predictD. Funding: ICS - Institut Català de la Salut. Duration: 2020 - 2022 |
The group participates in the following projects
|
PI: Bellon Saameño, Juan Angel. Prevención de la ansiedad y depresión por evaluación de riesgos: ensayo controlado aleatorio (El Estudio PANDORA). Funding: Instituto de Salud Carlos III. Duration: 2022 - 2024 |
|
PI: Aznar Lou, Ignacio. The impact of the COVID-19 pandemic and its restrictions on chronification of benzodiazepine use. Funding: Fundació per a la recerca i la docència Sant Joan de Déu (FSJD). Duration: 2022 - 2024 |
|
PI: Moreno Peral, Patricia. Efectividad de una intervención personalizada a través de internet basada en un algoritmo de riesgo para la prevención universal de la ansiedad: ensayo aleatorio controlado. El estudio prevANS.. Funding: Ministerio de Ciencia e Innovación . Duration: 2021 - 2024 |
|
PI: Bellon Saameño, Juan Angel. Prevención universal de la depresión y ansiedad en población general mediante una intervención personalizada basada en algoritmos de riesgo, TICs y sistemas de ayuda a las decisiones: ensayo controlado aleatorio. El estudio PredictPlusPrevent. Funding: Junta de Andalucia. Duration: 2019 - 2022 |
Group publications
|
Carbonell C, Rubio M, Marqués S, Peñarrubia MT, Gil MM, Pasarín MI, Parody E, Aznar I. Pediatric Medication Non-Initiation in Spain. Pediatrics. 2022;1(149):e2020034371-e202003437. PMID:34957504. IF: 7,124. |
|
Corral-Partearroyo C, Sánchez-Viñas A, Gil-Girbau M, Peñarrubia-María MT, Aznar-Lou I, Gallardo-González C, Olmos-Palenzuela MDC, Rubio-Valera M. Complex multidisciplinary intervention to improve Initial Medication Adherence to cardiovascular disease and diabetes treatments in primary care (the IMA-cRCT study): mixed-methods process evaluation protocol. BMJ Open. 2022 Oct; 12(10):e067468. doi:10.1136/bmjopen-2022-067468. Epub 2022 Oct 31. pmc:PMC9628671. PMID:36316078. IF: 3,007. |
|
Corral-Partearroyo C, Sánchez-Viñas A, Gil-Girbau M, Peñarrubia-María MT, Aznar-Lou I, Serrano-Blanco A, Carbonell-Duacastella C, Gallardo-González C, Olmos-Palenzuela MDC, Rubio-Valera M. Improving Initial Medication Adherence to cardiovascular disease and diabetes treatments in primary care: Pilot trial of a complex intervention. Front Public Health. 2022 ; 10:1038138. doi:10.3389/fpubh.2022.1038138. Epub 2022 Dec 06. pmc:PMC9764337. PMID:36561857. IF: . |
|
Gil-Girbau M, Peñarrubia-Maria MT, Carbonell-Simeón D, Rodríguez-Ferraz B, Contaldo SF, Iglesias-González M, Fernández-Vergel R, Blanco-García E, Baladon-Higuera L, Serrano-Blanco A, Rubio-Valera M. Assessment of a Primary Support Program: family physicians and mental health professionals' perspective. Fam Pract. 2022 Mar; doi:10.1093/fampra/cmac013. Epub 2022 Mar 04. PMID:35244164. IF: 2,267. |
|
Peñarrubia MT, Sanchez A, Corral C, Gallardo MD, Olmos MC, Fernández R, Mendive JM, Gil M, Aznar I, Rubio M. Impacte Clínic i econòmic de la No Iniciació dels tractaments de prevenció primària de malalties cardiovasculars. Butlletí de la CAMFIC. 2022;40(iss4):1-9. IF: . |
|
Recio-Rodriguez JI, Garcia-Ortiz L, Garcia-Yu IA, Lugones-Sanchez C, Olmo EZ, Bolibar B, Casajuana-Closas M, Lopez-Jimenez T, Llobera J, Ramos R, Pombo H, Motrico E, Gil-Girbau M, Lopez-Mendez F, Represas-Carrera F, Maderuelo-Fernandez JA. Effectiveness of a multiple health-behaviour-change intervention in increasing adherence to the Mediterranean Diet in adults (EIRA study): a randomized controlled hybrid trial. BMC Public Health. 2022 Nov; 22(1):2127. doi:10.1186/s12889-022-14590-y. Epub 2022 Nov 19. pmc:PMC9675247. PMID:36401247. IF: . |
|
Sánchez-Viñas A, Corral-Partearroyo C, Gil-Girbau M, Peñarrubia-María MT, Gallardo-González C, Olmos-Palenzuela MD, Aznar-Lou I, Serrano-Blanco A, Rubio-Valera M. Effectiveness and cost-effectiveness of an?intervention to improve?Initial Medication Adherence?to treatments for cardiovascular diseases and diabetes in primary care: study protocol for a pragmatic cluster randomised controlled trial and economic model (the IMA-cRCT study). BMC Prim Care. 2022 07; 23(1):170. doi:10.1186/s12875-022-01727-6. Epub 2022 Jul 05. PMID:35790915. IF: . |
|
Santos A, Crespo I, Pérez-Aranda A, Beltrán-Ruiz M, Puebla-Guedea M, García-Campayo J. Attachment-Based Compassion Therapy for Reducing Anxiety and Depression in Fibromyalgia. Int J Environ Res Public Health. 2022 Jul; 19(13). doi:10.3390/ijerph19138152. Epub 2022 Jul 02. pmc:PMC9265807. PMID:35805810. IF: 4,614. |
The group participates in the following publications
|
Bischoff SC, Barazzoni R, Busetto L, Campmans-Kuijpers M, Cardinale V, Chermesh I, Eshraghian A, Kani HT, Khannoussi W, Lacaze L, Léon-Sanz M, Mendive JM, Müller MW, Ockenga J, Tacke F, Thorell A, Vranesic Bender D, Weimann A, Cuerda C. European guideline on obesity care in patients with gastrointestinal and liver diseases - Joint ESPEN/UEG guideline. Clin Nutr. 2022 Oct; 41(10):2364-2405. doi:10.1016/j.clnu.2022.07.003. Epub 2022 Aug 12. PMID:35970666. IF: 7,324. |
|
Bischoff SC, Barazzoni R, Busetto L, Campmans-Kuijpers M, Cardinale V, Chermesh I, Eshraghian A, Kani HT, Khannoussi W, Lacaze L, Léon-Sanz M, Mendive JM, Müller MW, Ockenga J, Tacke F, Thorell A, Vranesic Bender D, Weimann A, Cuerda C. European guideline on obesity care in patients with gastrointestinal and liver diseases - Joint European Society for Clinical Nutrition and Metabolism / United European Gastroenterology guideline. United European Gastroenterol J. 2022 Sep; 10(7):663-720. doi:10.1002/ueg2.12280. Epub 2022 Aug 12. pmc:PMC9486502. PMID:35959597. IF: 4,623. |
|
Hungin APS, Scarpignato C, Keefer L, Corsetti M, Anastasiou F, Muris JWM, Mendive JM, Kahrilas PJ. Review article: rethinking the "ladder" approach to reflux-like symptom management in the era of PPI "resistance" - a multidisciplinary perspective. Aliment Pharmacol Ther. 2022 Jun; 55(12):1492-1500. doi:10.1111/apt.16930. Epub 2022 Apr 22. pmc:PMC9324949. PMID:35460095. IF: 8,171. |
|
Morse DF, Sandhu S, Mulligan K, Tierney S, Polley M, Chiva Giurca B, Slade S, Dias S, Mahtani KR, Wells L, Wang H, Zhao B, De Figueiredo CEM, Meijs JJ, Nam HK, Lee KH, Wallace C, Elliott M, Mendive JM, Robinson D, Palo M, Herrmann W, Østergaard Nielsen R, Husk K. Global developments in social prescribing. BMJ Glob Health. 2022 May; 7(5). doi:10.1136/bmjgh-2022-008524. pmc:PMC9115027. PMID:35577392. IF: . |
|
Riba F, Guarner-Argente C, Solanes M, Francia E, Garcia-Iglesias P, Machlab S, Mascort J, Mendive JM, Ortiz J, Calvet X. . Gastroenterol Hepatol. 2022 Mar; doi:10.1016/j.gastrohep.2022.03.004. Epub 2022 Mar 09. PMID:35278501. IF: 2,102. |
|
Savarino E, Anastasiou F, Labenz J, Hungin APS, Mendive J. Holistic management of symptomatic reflux: rising to the challenge of proton pump inhibitor overuse. Br J Gen Pract. 2022 Nov; 72(724):541-544. doi:10.3399/bjgp22X721157. Epub 2022 Oct 27. pmc:PMC9591095. PMID:36302677. IF: 5,386. |
Awards
|
Premi al millor treball de recerca. VI Congrés Català d?Infermeria de Salut Mental. Impacte del locus de control en la salut mental de la població adulta de Barcelona. Arroyo P, Olmos M, Gallardo M, Vicens E, Albas L, Raya A. |
|
Premi Sanitat Baix Llobregat 2021 a la Mejor Publicación en el ámbito de Atención Primaria. Health Soc Care Community 2021; 00: 1-9 Article DOI: 10.1111/hsc.13431. Non-initiation of prescribed medication from a Spanish health professionals? perspective: a qualitative exploration based on Grounded Theory. Peñarrubia M, Gil M, Gallardo M, Aznar I, Serrano A, Mendive J, Rubio M. |
|
Premi 2022 al millor article publicat en una revista d'accés obert al 2021. Dotat amb 1.000 EUR a la publicació Who Suffers From Pharmaceutical Poverty and What Are Their Needs? Evidence From a Spanish Region (Autors: Maria Rubio-Valera, Silvia Marqués-Ercilla, M Teresa Peñarrubia-María, Rosa M Urbanos-Garrido, Carme Borrell, Jordi Bosch, Alba Sánchez-Viñas, Ignacio Aznar-Lou), atorgat pel COFB. |
Indicators
|
Indicator |
2022 |
|---|---|
|
Researchers with PhD |
10 |
|
Total number of projects in which group members have participated |
11 |
|
Total number of projects in which the PI of the project has belonged to the group |
7 |
|
Total Funding |
630.885,79€ |
|
Scientific publications in indexed journals |
9 |
|
Total Impact factor |
44,618 |
|
Nº of articles in Q1 journals |
5 |
|
Q1 IF |
32,619 |
|
Nº of articles in Q2 journals |
2 |
|
Q2 IF |
13,557 |
